Posts tagged
impact covid
NeuBase Therapeutics Provides Business and Financial Update
Paul H. Williams
February 11, 2022
Enabling Investigational New Drug (IND) studies for the Myotonic Dystrophy Type 1 (DM1) program development candidate continue as planned; invited […]